MedPath

Acupuncture treatment for migraine carried out by senior or junior acupuncturists :a randomized controlled trial

Not Applicable
Recruiting
Conditions
Migraine
Registration Number
ITMCTR2100004370
Lead Sponsor
Chengdu University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged from 18 to 65 years;
2. Migraine without aura patients: meetting the ICHD-3 2018 edition diagnostic criteria for migraine (without aura) published by the International Headache Society;
3. With a history of migraine for over 6 months;
4. Migraine attacks more than once a month in the past 3 months;
5. Did not receive no acupuncture treatment in the past 3 months;
6. Did not take any preventive, long-acting analgesics, psychotropic drugs (such as Prozac and estazolam eurodin) or vasoactive drugs for migraine in the past 3 months;
7. The informed consent is signed by the patient himself or his immediate family member.
Note: Only those who meet each of the above 7 criteria can be included in the study.

Exclusion Criteria

1. Suffering from other pain conditions;
2. Suffering from mental disorders (such as primary anxiety, primary depression, schizophrenia, etc.);
3. Suffering from cognitive and consciousness disorder who cannot comply with the experiment procedure;
4. Suffering from cancer, circulation, phumalnory, urinary, hematopoietic and other systems serious primary diseases;
5. Being pregnant or lactating;
6. Patients who have a history of alcohol or drug abuse or drug addiction;
7. Having acupuncture contradictions.
Note: Those who meet any of the above 7 criteria should be excluded in the study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Days of headache;Number of headache attacks;
Secondary Outcome Measures
NameTimeMethod
Effective rate;Average VAS scores for headaches;MSQ;The use of non-steroidal drug;MIDAS;Emotion-related scale;
© Copyright 2025. All Rights Reserved by MedPath